Over the weekend the COVID-19 situation improved all the EU5 countries. Not only did the growth in net active infection rate fall in all countries, but new cases at least stabilized across the region. In particular Italy resumed the fall in the growth of net active cases, reaching 5% on Sunday, and new cases started to fall as well. It…
COVID-19 Europe: J.P. Morgan
A financial market resource for the every-day investor and trader.
-
The Leuthold Group: August Green Book
Seth Golden, , Research Reports, 0
The month of October gets all the “love,” but since 1990, August has been the cruelest month for stocks....
-
Pantheon Macro: Q4 2022 ECI Economic Monitor
Seth Golden, , Research Reports, 0
The ECI is the best measure of wage growth, but you still need to look under the hood, not...
-
J.P. Morgan Special Report: Wait for it
Seth Golden, , Research Reports, 0
2023 Global Economic Outlook • With financial conditions tightening and the winter aggravating China’s COVID and Europe’s natural gas...
-
Found A Bottom? Bridge To The Other Side
Seth Golden, , Research Reports, 0
After a strong relief rally, the S&P 500 (SPX) once again suffered from selling pressure and ended in the...
-
Are We Shorting Volatility And How
Seth Golden, , Research Reports, 0
Over the last few years I have become increasingly vocal and accurate with my prognostications concerning volatility and the...
-
Uncertainty to Give Way: Lower Valuation Levels Rarely Last
Seth Golden, , Research Reports, 0
Despite what has now been a near 10% S&P 500 (SPX) correction from it’s all-time high set in September,...
-
Fitbit And Medtronic: Headlines Vs. Reality
Seth Golden, , Research Reports, 0
You will hear plenty of commentary from Fitbit (FIT) fans and investors regarding the future of Fitbit with a...
-
Super Bowl Of Volatility At-Hand: Navigating The Field Ahead
Seth Golden, , Research Reports, 3
The Grand Market Sell-Off: Is that what we’ll be calling the pullback in the indexes in the coming weeks?...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00